Key terms
About IRTC
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest IRTC news
Mar 10
5:31pm ET
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
Mar 05
5:01am ET
Analysts’ Top Healthcare Picks: Avidity Biosciences (RNA), Irhythm Technologies (IRTC)
Mar 04
6:49am ET
iRhythm files to sell $450M of convertible senior notes due 2029
Feb 29
4:57pm ET
iRhythm partners with Epic for Zio access
Feb 28
6:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Irhythm Technologies (IRTC), Ventyx Biosciences (VTYX) and Rewalk Robotics (LFWD)
Feb 28
6:19am ET
iRhythm price target raised to $135 from $125 at Wells Fargo
Feb 28
5:50am ET
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Tarsus Pharmaceuticals (TARS) and Springworks Therapeutics (SWTX)
Feb 23
7:46am ET
Irhythm Technologies: Poised for Growth Despite Challenges
Feb 23
7:19am ET
iRhythm price target raised to $133 from $121 at Canaccord
Feb 23
6:35am ET
iRhythm price target raised to $135 from $125 at Baird
Feb 23
6:01am ET
Analysts Conflicted on These Healthcare Names: C4 Therapeutics (CCCC), Eli Lilly & Co (LLY) and Irhythm Technologies (IRTC)
Feb 23
5:40am ET
Analysts Are Bullish on Top Healthcare Stocks: Veracyte (VCYT), Irhythm Technologies (IRTC)
Feb 22
4:19pm ET
iRhythm sees FY24 revenue $575M-$585M, consensus $581.06M
Feb 22
4:18pm ET
iRhythm reports Q4 EPS (84c), consensus (60c)
Feb 07
2:35pm ET
SHAREHOLDER ALERT: Potential Recovery for iRhythm Technologies, Inc. (IRTC) Investors
Jan 30
9:25pm ET
Truist Financial Remains a Buy on Irhythm Technologies (IRTC)
Jan 09
7:46am ET
iRhythm Technologies: Strong Buy Rating on Positive Performance Indicators and Future Growth Prospects
Jan 09
6:30am ET
Analysts’ Top Healthcare Picks: Biora Therapeutics (BIOR), Irhythm Technologies (IRTC)
Jan 09
5:08am ET
Irhythm Technologies Poised for Strong Growth: A Buy Rating from Nathan Treybeck
Jan 08
11:00am ET
Analysts Are Bullish on Top Healthcare Stocks: Irhythm Technologies (IRTC), Asensus Surgical (ASXC)
Jan 08
8:39am ET
iRhythm reports closing of five-year debt facility
Jan 08
8:38am ET
iRhythm says grew Q4 patient registrations in excess of 22% y/y
Jan 08
8:38am ET
iRhythm sees FY24 revenue $575M-$585M, consensus $578.72M
Jan 07
5:31am ET
BTIG Keeps Their Buy Rating on Irhythm Technologies (IRTC)
Jan 05
8:15am ET
iRhythm announces results from CAMELOT study have been published
Jan 03
8:11am ET
iRhythm receives CE Marking under EU MDR for Zio monitor, ZEUS System
Jan 02
6:10pm ET
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), AbbVie (ABBV) and CymaBay Therapeutics (CBAY)
Jan 02
5:53pm ET
iRhythm Tracker implies 12% upside to Q4 revenue consensus, says Wells Fargo
Jan 02
9:17am ET
Irhythm Technologies (IRTC) Receives a Buy from BTIG
Dec 31
5:17am ET
BTIG Keeps Their Buy Rating on Irhythm Technologies (IRTC)
Dec 25
9:30pm ET
Analysts Offer Insights on Healthcare Companies: Vericel (VCEL), Irhythm Technologies (IRTC) and Meiragtx Holdings (MGTX)
No recent news articles are available for IRTC
Today
12:09pm ET
IRTC DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Mar 26
9:21pm ET
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 26
12:50pm ET
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Mar 25
9:41am ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 25
6:00am ET
IRHYTHM INVESTOR ALERT: Kirby McInerney LLP Notifies iRhythm Technologies, Inc. (IRTC) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
Mar 24
9:22am ET
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 21
11:49am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC
Mar 20
5:14pm ET
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTC
Mar 18
1:46pm ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm Technologies
Mar 17
5:01pm ET
ROSEN, NATIONAL TRIAL COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTC
Mar 15
9:49am ET
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 13
8:35am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC
Mar 12
6:52am ET
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTC
IRTC Financials
Key terms
Ad Feedback
IRTC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
IRTC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range